Chargement en cours...
Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?
BACKGROUND/HISTORICAL PERSPECTIVE: Availability of biologic disease-modifying antirheumatic drugs (bDMARDs) has improved clinical outcomes in rheumatoid arthritis, but it also increased the cost of treatment. Biosimilars, the regulated copies of biologic products, have a potential to reduce health c...
Enregistré dans:
| Publié dans: | J Clin Rheumatol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6392209/ https://ncbi.nlm.nih.gov/pubmed/30059414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000881 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|